Skip to content

Supplier News

P&G names Taylor as next CEO

P&G names Taylor as next CEO

David Taylor, Procter & Gamble Co.’s group president of global beauty, grooming and health care, has been chosen to succeed A.G. Lafley as the company’s president and chief executive officer. P&G said late Tuesday that Taylor is slated to take the helm as CEO on Nov.

Sandoz releases Pulmicort Respules generic

Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage.

Teva to buy Allergan Generics for $40.5 billion

Teva to buy Allergan Generics for $40.5 billion

Teva Pharmaceutical Industries Ltd. plans to buy Allergan’s generic drug business for about $40.5 billion and, with the deal, has withdrawn its proposal to acquire Mylan N.V. for approximately $40 billion. Teva said Monday that Dublin, Ireland-based Allergan will receive $33.

Performance Health launches Atomic Heat

Performance Health launches Atomic Heat

Performance Health LLC has expanded its roster of topical analgesic, rehabilitation and wellness products with Perform Atomic Heat, a new topical formula for warming the body before physical activity and relieving muscle, joint and arthritis pain.

Lupin to acquire Gavis Pharmaceuticals

Lupin to acquire Gavis Pharmaceuticals

Lupin Ltd. plans to buy Gavis Pharmaceuticals LLC and Novel Laboratories Inc. in an $880 million deal. Lupin said Thursday that the acquisition will boost its scale in the U.S.

Markwins names Rogers as Physicians Formula president

Jeff Rogers has been appointed as president of the Physicians Formula Group at Markwins International Corp. Rogers takes over from Ingrid Jackel, who left the company to join natural beauty care manufacturer Yes To Inc. as chief executive officer.

Coalition formed to safeguard access to OTC pain relievers

Coalition formed to safeguard access to OTC pain relievers

A group of drug- and health-related companies and organizations have formed the Protecting Access to Pain Relief Coalition (PAPR), which seeks to preserve Americans’ access to and choice of safe, effective pain relief best-suited for their condition.

GPhA tabs Davis as new CEO

GPhA tabs Davis as new CEO

Chester “Chip” Davis has been named president and chief executive officer of the Generic Pharmaceutical Association (GPhA), taking over from Ralph Neas, who is stepping down.

Qore-24 hits shelves at Walgreens stores

Qore-24 hits shelves at Walgreens stores

Qore-24, an antimicrobial hand purifier that kills germs for up to 24 hours, has landed retail distribution at Walgreens. Qore Systems, the maker of Qore-24, said Tuesday that the product began rolling out to 3,700 Walgreens stores nationwide earlier this month.

Yes To tabs Jackel as CEO

Yes To tabs Jackel as CEO

Ingrid Jackel is joining natural beauty care manufacturer Yes To Inc. as chief executive officer. Yes To said Monday that Jackel comes to Yes To from Physicians Formula, where she held a variety of positions, including CEO, president and chairwoman.

Galderma set to launch Epiduo Forte Gel

Galderma set to launch Epiduo Forte Gel

Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.